Compareing effects of venlafaxine and Placebo on depression, withdrawal symptoms, craving
Phase 2
- Conditions
- Addiction.Mental and behavioral disorders due to use of other stimulants, including caffeine: dependence syndromes
- Registration Number
- IRCT20160717028967N8
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 66
Inclusion Criteria
Gender Male
Methamphetamine dependence diagnoses accordingly Diagnostic and Statistical Manual of Mental Disorders fifth edition
The dominant use of methamphetamine for at least 6 months
lack of serious psychiatric disorders
Exclusion Criteria
Gender female
No use of other drugs and stimulants at the time of entering the study
The absence of comorbid psychiatric disorders symptoms
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression. Timepoint: before intervention- 4 weeks later- 8 weeks later. Method of measurement: Depression Inventory.;Withdrawal symptoms. Timepoint: before intervention- 4 weeks later- 8 weeks later. Method of measurement: Inventory withdrawal symptoms.;Craving. Timepoint: before intervention- 4 weeks later- 8 weeks later. Method of measurement: Craving Questionnaire.
- Secondary Outcome Measures
Name Time Method